drugset / Trial / NCT00285415
A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of the combination of the two drugs, docetaxel (Taxotere®) and carboplatin (Paraplatin®) followed by radiation directed at the tumor in treating your endometrial cancer.
Timeline
- Start
- 2005-04
- Primary completion
- 2012-04
- Completion
- 2012-06
Outcome
Outcome not reported
Stopped: “Investigator abruptly left Carilion.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 6 unknown | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |